Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
Top Research Reports for AT&T, Home Depot & Cisco

23h zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AT&T (T), Home Depot (HD) and Cisco (CSCO). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
HD CBSH LMT CBSHP BSX NYLD VEEV TWX TWC NYLD.A CBCB BYD

0
NRG: Long-Term Promise, Short-Term Uncertainty

2018-07-12 seekingalpha
NRG Energy is a major provider of wholesale electricity to the United States, producing electricity from a diverse mix of fuels.
NRGEO SOJA NRG SO NYLD NYLD.A

0
NRG: Successful Restructuring Should Yield Outsized Returns

2018-07-05 seekingalpha
The company has had some financial problems recently as a cutthroat rate war in the industry has left it overburdened with debt.
NRGEO NRG NYLD NYLD.A

1
25 'Safer' Dividend Utilities Show Positive Returns And Cash To Boot

2018-06-27 seekingalpha
Ten top "safer" high yield dividend Utilities showed 7.7%-44.6% net as of June 25, 2018, broker targets.
GASNF RDEIY NYLD AY ENGQF RDEIF CAFD CPXWF NYLD.A GASNY

18
50 Top-Yield Utilities Stocks For June

2018-06-27 seekingalpha
CAFD, TERP, HGKGY, APU, CESDY, NYLD, PEGI, BEP, AY and SBS were the top ten net gain Utilities per broker targeted 1yr. prices showing a combined 15.9% average net 6/25/18.
PEGI AY RDEIF HGKGF HGKGY RDEIY NYLD APU PEG CAFD NYLD.A TERP

66
40 Russell 3000 'Safer' Dividend Stocks For June

2018-06-11 seekingalpha
40 of 104 Russell 3000 Index stocks were deemed "safer" for dividends because they showed positive one-year returns and free cash flow yields greater than their dividend yields.
ANH.PRA GEO GMRE.PRA ANH.PRC ANH.PRB ANH ORC LADR CIM GMRE CYS.PRA NYLD CLNS.PRDCL CYS.PRB CORR.PRA AGNC NYLD.A CORR CIM.PRA CLNS IVR.PRA IVR.PRB CLNS.PRJ CLNS.PRI IVR.PRC CLNS.PRH DX NLY GLPI NLY.PRA CLNS.PRG CLNS.PRE NLY.PRECL NLY.PRD CLNS.PRD NLY.PRE CIM.PRB CLNS.PRB CYS NLY.PRC NLY.PRF NLY.PRG IVR DX.PRB DX.PRA

24
FuelCell Energy, Inc. (FCEL) CEO Chip Bottone on Q2 2018 Results - Earnings Call Transcript

2018-06-07 seekingalpha
Good morning. My name is Tiffany and I will be your conference operator today. At this time, I would like to welcome everyone to the FuelCell Energy's Second Quarter 2018 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
NRGEO HTGZ SOJA NRG SO NYLD FCELB HTGC NYLD.A HTGX FCEL HTGY

18
FuelCell Energy Reports Second Quarter 2018 Financial Results and Business Update

2018-06-07 globenewswire
DANBURY, Conn., June 07, 2018 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today reported financial results for the three and six-month periods ended April 30, 2018 and key business highlights.
NRGEO NRG NYLD FCELB NYLD.A FCEL

22
64 WallStar Utilities Stocks Per Broker May Targets

2018-05-25 seekingalpha
JE, SPKE, & SBS led the top ten WallStar Utilities per broker targeted price gains with combined 61.8% average net gains while 7 trailing combined for 24.5% average gains 5/23/18.
JE DUKH PEGI SCG SPKE AY DUK JE NYLD APU PPL PEG CAFD SPH NYLD.A JE.PRA TERP

15
Pattern Energy Group: Go Where The Wind Blows

2018-05-22 seekingalpha
Pattern Energy Group is an independent power producer that operates a primarily wind-focused portfolio of 25 projects in the U.S., Canada, Japan, and Chile.
VSLR PEGI NYLD PEG CAFD FSLR NYLD.A TERP

90
Cheniere Energy Partners downgraded to neutral from overweight at J.P. Morgan

2018-05-15 marketwatch
Cheniere Energy (LNG) saw three upward target price revisions following its 1Q18 earnings. These changes could be due to an increase in its 2018 guidance.
TRP CQP CLMT LNG MS.PRE MS.PRF MS.PRG NEP MS.PRA MS.PRI MS.PRK NYLD CQH MS PLX NYLD.A

158
5 Notable Dividend Increases From the Past Week — Including Apple Inc.

2018-05-07 investorplace
The S&P 500 headed slightly lower last week as a solid employment report on Friday helped the market recoup earlier losses. High expectations heading into earnings season, plus lingering trade war concerns and uncertainty over the Fed’s plans to raise rates, all weighed on sentiment. However, a handful of businesses added some good news with dividend increases.
SOHOL NYLD AAPL SOHOB SOHO CHCT TRTN NYLD.A SOHOM

9
NRG Yield's (NYLD) CEO Chris Sotos on Q1 2018 Results - Earnings Call Transcript

2018-05-05 seekingalpha
Good day, ladies and gentlemen, and welcome to the NRG Yield First Quarter 2018 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. As a reminder, this call is being recorded.
NRGEO NRG DB NYLD NYLD.A

0
BRIEF-NRG Yield Files Prospectus Supplement Relates To The $99.3 Mln Aggregate Offering Price Of Shares Of Co's Class C Common Stock

2018-05-04 reuters
* NRG YIELD INC FILES PROSPECTUS SUPPLEMENT RELATES TO THE $99.3 MILLION AGGREGATE OFFERING PRICE OF SHARES OF CO’S CLASS C COMMON STOCK - SEC FILING
NYLD NYLD.A

0
NRG Yield, Inc. 2018 Q1 - Results - Earnings Call Slides

2018-05-03 seekingalpha
The following slide deck was published by NRG Yield, Inc. in conjunction with their 2018 Q1 earnings call.
NYLD NYLD.A

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 62942X306